DXB Quarterly Appendix 4C and Activities Report 25/07/25 PRICE SENSITIVE download Created with Sketch. 689.15KB Share DXB Dimerix receives 1st Development Milestone payment from FUSO 30/06/25 PRICE SENSITIVE download Created with Sketch. 347.49KB Share DXB ACTION3 Clinical Trial Milestone Recruitment Update 13/06/25 PRICE SENSITIVE download Created with Sketch. 327.97KB Share DXB 1st ACTION3 site in Japan activated and milestone triggered 30/05/25 PRICE SENSITIVE download Created with Sketch. 411.45KB Share DXB Successful planned IDMC review of ACTION3 trial 22/05/25 PRICE SENSITIVE download Created with Sketch. 314.71KB Share DXB Dimerix receives initial upfront payment from Amicus 06/05/25 PRICE SENSITIVE download Created with Sketch. 325.79KB Share DXB Investor Webinar and Presentation 01/05/25 PRICE SENSITIVE download Created with Sketch. 2.57MB Share DXB Dimerix Licenses DMX-200 in the US 01/05/25 PRICE SENSITIVE download Created with Sketch. 335.92KB Share DXB Quarterly Appendix 4C and Activities Report 30/04/25 PRICE SENSITIVE download Created with Sketch. 545.42KB Share DXB Trading Halt 29/04/25 PRICE SENSITIVE download Created with Sketch. 434.81KB Share DXB FDA confirms Proteinuria as Primary Endpoint for US approval 28/04/25 PRICE SENSITIVE download Created with Sketch. 359.86KB Share DXB S&P DJI Announces March 2025 Quarterly Rebalance 07/03/25 PRICE SENSITIVE download Created with Sketch. 174.42KB Share DXB Dimerix receives initial upfront payment from FUSO 04/03/25 PRICE SENSITIVE download Created with Sketch. 402.28KB Share DXB Half-Year Financial Report & Appendix 4D - 31 December 2024 25/02/25 PRICE SENSITIVE download Created with Sketch. 2.1MB Share DXB Quarterly Appendix 4C and Activities Report 28/01/25 PRICE SENSITIVE download Created with Sketch. 804.33KB Share DXB First Paediatric Patient Recruited for ACTION3 16/01/25 PRICE SENSITIVE download Created with Sketch. 387.81KB Share DXB Dimerix enters Development and License Agreement for Japan 07/01/25 PRICE SENSITIVE download Created with Sketch. 357.12KB Share DXB DMX-200 ACTION3 Phase 3 Trial Part 2 Recruitment Complete 30/12/24 PRICE SENSITIVE download Created with Sketch. 350.16KB Share DXB Successful planned IDMC review of ACTION3 trial 20/11/24 PRICE SENSITIVE download Created with Sketch. 258.63KB Share DXB Dimerix Receives $7.9M R&D Tax Incentive Rebate 15/11/24 PRICE SENSITIVE download Created with Sketch. 338.36KB Share DXB NEPTUNE Study Network to Enhance Phase 3 Recruitment in US 01/11/24 PRICE SENSITIVE download Created with Sketch. 369.19KB Share DXB Quarterly Appendix 4C and Activities Report 31/10/24 PRICE SENSITIVE download Created with Sketch. 498.81KB Share DXB Project PARASOL Update & Medical Advisory Board Appointment 28/10/24 PRICE SENSITIVE download Created with Sketch. 373.43KB Share DXB ACTION3 Trial Recruitment and Multiregion Trial Site Update 16/09/24 PRICE SENSITIVE download Created with Sketch. 310.81KB Share DXB First Paediatric Site Activated and Trial Update 12/09/24 PRICE SENSITIVE download Created with Sketch. 321.53KB Share DXB First patient enters into Open Label Extension study 10/09/24 PRICE SENSITIVE download Created with Sketch. 306.9KB Share DXB Preliminary Final Report 29/08/24 PRICE SENSITIVE download Created with Sketch. 174.9KB Share DXB Quarterly Appendix 4C and Activities Report 23/07/24 PRICE SENSITIVE download Created with Sketch. 594.74KB Share DXB Adolescent Recruitment into ACTION3 Clinical Trial 04/07/24 PRICE SENSITIVE download Created with Sketch. 317.35KB Share DXB Dimerix and Taiba enter into License Agreement for DMX-200 27/05/24 PRICE SENSITIVE download Created with Sketch. 346.36KB Share DXB Dimerix Receives PIP Approval from the UK MHRA 01/05/24 PRICE SENSITIVE download Created with Sketch. 328.79KB Share DXB Quarterly Appendix 4C and Activities Report 22/04/24 PRICE SENSITIVE download Created with Sketch. 527.41KB Share DXB Dimerix Completes $20M Placement 12/03/24 PRICE SENSITIVE download Created with Sketch. 367.12KB Share DXB Trading Halt 11/03/24 PRICE SENSITIVE download Created with Sketch. 426.73KB Share DXB Dimerix Successfully Passes Efficacy Interim Analysis 11/03/24 PRICE SENSITIVE download Created with Sketch. 408.62KB Share DXB PH3 Data Collection Complete for First Interim Analysis 27/02/24 PRICE SENSITIVE download Created with Sketch. 351.5KB Share DXB Half-Year Financial Report & Appendix 4D - 31 December 2023 26/02/24 PRICE SENSITIVE download Created with Sketch. 1.05MB Share DXB Quarterly Appendix 4C and Activities Report 29/01/24 PRICE SENSITIVE download Created with Sketch. 486.14KB Share DXB ACTION3 IND Approved in China 28/11/23 PRICE SENSITIVE download Created with Sketch. 285.03KB Share DXB Dimerix Receives Initial Upfront Payment from Advanz Pharma 06/11/23 PRICE SENSITIVE download Created with Sketch. 373.92KB Share DXB Quarterly Appendix 4C and Activities Report 30/10/23 PRICE SENSITIVE download Created with Sketch. 669.16KB Share DXB Dimerix Announces License Agreement for EU, Canada, ANZ 05/10/23 PRICE SENSITIVE download Created with Sketch. 349.93KB Share DXB Trading Halt 04/10/23 PRICE SENSITIVE download Created with Sketch. 428.4KB Share DXB FDA Approves Qytovra Brand Name 25/09/23 PRICE SENSITIVE download Created with Sketch. 438.29KB Share DXB Regulatory Approval received in Malaysia for ACTION3 Study 22/09/23 PRICE SENSITIVE download Created with Sketch. 409.35KB Share DXB Dimerix Receives $8.9M R&D Tax Incentive Rebate 13/09/23 PRICE SENSITIVE download Created with Sketch. 369.5KB Share DXB Preliminary Final Report 30/08/23 PRICE SENSITIVE download Created with Sketch. 305.86KB Share DXB Successful Completion of 2nd DSMB Review of FSGS Trial 08/08/23 PRICE SENSITIVE download Created with Sketch. 371.69KB Share DXB Quarterly Appendix 4C and Activities Report 28/07/23 PRICE SENSITIVE download Created with Sketch. 646.25KB Share DXB DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24 24/07/23 PRICE SENSITIVE download Created with Sketch. 397KB Share DXB Approval received for Paediatric Investigation Plan from EMA 05/07/23 PRICE SENSITIVE download Created with Sketch. 340.9KB Share DXB Dimerix confirms Phase 3 study design appropriate for China 03/07/23 PRICE SENSITIVE download Created with Sketch. 369.74KB Share DXB Prospectus 26/06/23 PRICE SENSITIVE download Created with Sketch. 629.37KB Share DXB Dimerix Announces Update on Successful Capital Raise 05/06/23 PRICE SENSITIVE download Created with Sketch. 333.7KB Share DXB Rights Issue Prospectus 04/05/23 PRICE SENSITIVE download Created with Sketch. 867.89KB Share DXB Reinstatement to Official Quotation 04/05/23 PRICE SENSITIVE download Created with Sketch. 86.04KB Share DXB Entitlement offer and Convertible Note to raise $12 million 04/05/23 PRICE SENSITIVE download Created with Sketch. 400.75KB Share DXB Voluntary Suspension 03/05/23 PRICE SENSITIVE download Created with Sketch. 427.13KB Share DXB Trading Halt 01/05/23 PRICE SENSITIVE download Created with Sketch. 441.08KB Share DXB Quarterly Appendix 4C and Activities Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 575KB Share DXB Half-Year Financial Report & Appendix 4D - 31 December 2022 27/02/23 PRICE SENSITIVE download Created with Sketch. 946.74KB Share DXB DXB to Receive $2.8m in Prepayment of R&D Tax Incentive 17/02/23 PRICE SENSITIVE download Created with Sketch. 349.24KB Share DXB Successful Completion of DSMB Review of Phase 3 FSGS Trial 09/02/23 PRICE SENSITIVE download Created with Sketch. 339.4KB Share DXB Quarterly Appendix 4C and Activities Report 31/01/23 PRICE SENSITIVE download Created with Sketch. 663.86KB Share DXB FDA Confirms Inclusion of Paediatrics in ACTION3 Study 12/01/23 PRICE SENSITIVE download Created with Sketch. 348.11KB Share DXB DMX-200 FSGS Phase 3 Trial Part 1 Recruitment Achieved 15/12/22 PRICE SENSITIVE download Created with Sketch. 346.26KB Share DXB CLARITY 2.0 COVID-19 Study Outcome 13/12/22 PRICE SENSITIVE download Created with Sketch. 268.03KB Share DXB Chair address and CEO presentation to AGM 29/11/22 PRICE SENSITIVE download Created with Sketch. 2.72MB Share DXB Quarterly Appendix 4C and Activities Report 27/10/22 PRICE SENSITIVE download Created with Sketch. 522.62KB Share DXB Dimerix Receives A$6.0M R&D Tax Incentive Rebate 25/10/22 PRICE SENSITIVE download Created with Sketch. 322.4KB Share DXB Appendix 4E and 2022 Annual Report 29/08/22 PRICE SENSITIVE download Created with Sketch. 1.86MB Share DXB CLARITY 2.0 COVID-19 Study Concludes Recruitment 18/08/22 PRICE SENSITIVE download Created with Sketch. 260.33KB Share DXB New Patent Family Application for DMX-700 09/08/22 PRICE SENSITIVE download Created with Sketch. 267.59KB Share DXB Quarterly Appendix 4C and Activities Report 27/07/22 PRICE SENSITIVE download Created with Sketch. 539.64KB Share DXB DMX-700 Study Shows Significant 80% Reduction in Lung Injury 04/07/22 PRICE SENSITIVE download Created with Sketch. 358.13KB Share DXB REMAP-CAP COVID-19 Study Analysis Update 27/06/22 PRICE SENSITIVE download Created with Sketch. 257.28KB Share DXB New Clinical Trial for DMX-200 in Diabetic Kidney Disease 07/06/22 PRICE SENSITIVE download Created with Sketch. 287.61KB Share DXB Phase 3 FSGS Kidney Trial First Patient Recruited 31/05/22 PRICE SENSITIVE download Created with Sketch. 362.33KB Share DXB Dimerix presentation at Bioshares Biotech Summit 12/05/22 PRICE SENSITIVE download Created with Sketch. 4.15MB Share DXB FDA IND Approval for Phase 3 Study of DMX-200 in FSGS 09/05/22 PRICE SENSITIVE download Created with Sketch. 305.47KB Share DXB Quarterly Appendix 4C and Activities Report 27/04/22 PRICE SENSITIVE download Created with Sketch. 634.84KB Share DXB Dimerix Receives A$3.7M R&D Tax Incentive Rebate 29/03/22 PRICE SENSITIVE download Created with Sketch. 315.38KB Share DXB DSMB Change to REMAP-CAP COVID-19 Study 28/02/22 PRICE SENSITIVE download Created with Sketch. 300.56KB Share DXB Half-Year Financial Report & Appendix 4D - 31 December 2021 24/02/22 PRICE SENSITIVE download Created with Sketch. 927.83KB Share DXB First Regulatory Approval in Europe for DMX-200 FSGS Study 01/02/22 PRICE SENSITIVE download Created with Sketch. 305.98KB Share DXB Quarterly Appendix 4C and Activities Report 28/01/22 PRICE SENSITIVE download Created with Sketch. 517.61KB Share DXB Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India 11/01/22 PRICE SENSITIVE download Created with Sketch. 463.32KB Share DXB Ethics Approval in Australia for Phase 3 COVID-19 Study 23/12/21 PRICE SENSITIVE download Created with Sketch. 344.65KB Share DXB DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe 16/12/21 PRICE SENSITIVE download Created with Sketch. 336.58KB Share DXB Pause in Trading 16/12/21 PRICE SENSITIVE download Created with Sketch. 113.2KB Share DXB Quarterly Appendix 4C and Activities Report 25/10/21 PRICE SENSITIVE download Created with Sketch. 594.78KB Share DXB First Approvals Received for Start of Phase 3 FSGS Trial 21/10/21 PRICE SENSITIVE download Created with Sketch. 333.01KB Share DXB Phase 3 DMX-200 COVID-19 Study Expands into Australia 15/10/21 PRICE SENSITIVE download Created with Sketch. 346.69KB Share DXB Dimerix Closes SPP Oversubscribed 01/10/21 PRICE SENSITIVE download Created with Sketch. 317.3KB Share DXB DMX-200 CLARITY COVID-19 Study Approval in India 24/09/21 PRICE SENSITIVE download Created with Sketch. 349.78KB Share DXB Phase 3 Study in FSGS Kidney Patients Commences 25/08/21 PRICE SENSITIVE download Created with Sketch. 255.95KB Share DXB SPP and Options Prospectus 24/08/21 PRICE SENSITIVE download Created with Sketch. 665.62KB Share DXB Response to ASX Query 19/08/21 PRICE SENSITIVE download Created with Sketch. 303.57KB Share DXB Preliminary Final Report 16/08/21 PRICE SENSITIVE download Created with Sketch. 262.19KB Share DXB Successful $20m Placement to Fund Phase 3 Trials 16/08/21 PRICE SENSITIVE download Created with Sketch. 315.83KB Share
(20min delay)
